Home › Multiple Sclerosis › New Jersey
Multiple Sclerosis clinical trials in New Jersey
11 studies for Multiple Sclerosis are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Bridgewater
- TG Therapeutics Investigational Trial Site, Cherry Hill
- TG Therapeutics Investigational Trial Site, Freehold
- and 3 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Holy Name Medical Center- Site Number : 8400101, Teaneck
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 15, 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0131, New Brunswick
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 10, 2026 · NCT06408259A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice
- Novartis, East Hanover
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Aug 21, 2026 · NCT07779460A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
- Kessler Foundation, East Hanover
Recruiting
Ages 18 to 70 · All sexes · Updated Aug 5, 2026 · NCT06197685Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
- Bristol Myers Squibb, Lawrenceville
RecruitingObservational study
All ages · All sexes · Updated Jul 29, 2026 · NCT07732907Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
- Atlantic Health, Morristown
RecruitingPhase 4
Ages 18 and older · Women · Updated May 29, 2026 · NCT07614321Multiple Sclerosis Implementation Network (Registry)
- Multiple Sclerosis Association of America, Cherry Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07415824Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
- Kessler Foundation, West Orange
Recruiting
Ages 18 to 75 · All sexes · Updated Nov 24, 2025 · NCT04855825Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community
- Kessler Foundation, East Hanover
Recruiting
Ages 19 to 65 · All sexes · Updated Feb 21, 2025 · NCT06608797From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.